Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

OP10: Efficacy and safety of upadacitinib in patients with moderately to severely active Crohn’s Disease: results from the U-ENDURE long-term extensionECCO'24 Stockholm
Year: 2024
Authors: D'Haens, Geert
OP11: Exploring the potential clinical utility of NUDT15 pharmacogenetic testing in clinical practice: a ‘focused reverse phenotyping’ study in the UK IBD BioresourceECCO'24 Stockholm
Year: 2024
Authors: Roberts, Christopher
OP12: Mirikizumab improves fatigue, bowel urgency, and quality of life in patients with moderately to severely active Crohn’s Disease: Results from a phase 3 clinical trialECCO'24 Stockholm
Year: 2024
Authors: Travis, Simon
OP13: Anti-integrin ⍺vβ6 autoantibodies are increased in PSC-IBD and correlate with liver disease severityECCO'24 Stockholm
Year: 2024
Authors: Bloemen, Hannah
OP14: Effect of mirikizumab on clinical and endoscopic outcomes after 1 anti-TNF failure in patients with moderately to severely active Ulcerative ColitisECCO'24 Stockholm
Year: 2024
Authors: Hart, Ailsa
OP15: High-definition white light endoscopy with segmental re-inspection is non-inferior compared to dye-based chromoendoscopy in Inflammatory Bowel Disease: the randomized controlled HELIOS trialECCO'24 Stockholm
Year: 2024
Authors: Te Groen, Maarten
OP16: A novel artificial intelligence-assisted Image Enhanced Endoscopy assesses accurately @@DHKOM@@vascular-healing@@DHKOM@@ and predicts long-term clinical relapse in patients with ulcerative colitis: a prospective cohort study.ECCO'24 Stockholm
Year: 2024
Authors: Maeda, Yasuharu
OP17: IBD ulcers are characterized by bioactive interleukin-1 and transcriptomic hallmarks of stromal cell state reprogrammingECCO'24 Stockholm
Year: 2024
Authors: Mitsialis, Vanessa
OP18: Efficacy and safety of darvadstrocel treatment in patients with complex perianal fistulas and Crohn’s Disease: results from the global ADMIRE-CD II phase 3 studyECCO'24 Stockholm
Year: 2024
Authors: Serclova, Zuzana
OP19: Extended mesenterectomy is not superior to mesenteric sparing resection in primary ileocolic resection for Crohn’s Disease in terms of postoperative endoscopic recurrence – results of an international randomised controlled trialECCO'24 Stockholm
Year: 2024
Authors: Van Der Does De Willebois, Eline
OP20: Postoperative endoscopic recurrence after resection of Crohn’s terminal ileitis with Kono-S or side-to-side functional end anastomosis: results of a Multicenter Prospective Randomized TrialECCO'24 Stockholm
Year: 2024
Authors: Trencheva, Koianka
OP21: Spatial Transcriptomics of Pre-treatment Biopsies Revealing Molecular Maturation State and Chronic Crypt Damage, Reflecting Histological Severity, as Predictors of Primary Responsiveness to TNF-α Inhibitors in Bio-naive Ulcerative Colitis PatientsECCO'24 Stockholm
Year: 2024
Authors: Kim, So-Woon
OP22: Topical Sphingosine-1-Phosphate (S1P) Receptor 1 Modulation Regulates Gut Angiogenesis in Inflammatory Bowel DiseasesECCO'24 Stockholm
Year: 2024
Authors: Rieder, Florian
OP23: Guselkumab induction restores intestinal immune homeostasis and promotes epithelial repair in moderately to severely active Ulcerative ColitisECCO'24 Stockholm
Year: 2024
Authors: Verstockt, Bram
OP24: SPP1 in colitis-associated colon cancerECCO'24 Stockholm
Year: 2024
Authors: Manna, Subhakankha
OP25: Dual activation of GCGR/GLP1R signaling ameliorates intestinal fibrosis via metabolic regulation of histone H3K9 lactylation in epithelial cellsECCO'24 Stockholm
Year: 2024
Authors: Liu, Han
OP26: Programmable probiotic local delivery of anti-TNF-α nanobody to alleviate DSS-induced colitisECCO'24 Stockholm
Year: 2024
Authors: Kang, Guangbo
OP27: Oxalyl-CoA decarboxylase is a major and specific virulence factor for Adherent Invasive Escherichia coliECCO'24 Stockholm
Year: 2024
Authors: Toumi, Eya
OP28: Defective STAT3 signaling in refractory Very Early Onset Inflammatory Bowel Disease is associated with a transcriptional signature which predicts response to anti-IL23-based therapiesECCO'24 Stockholm
Year: 2024
Authors: Collen, Lauren
OP29: Haematopoietic stem cell gene therapy as a treatment for severe Crohn’s Disease associated with pathogenic NOD2 genetic variantsECCO'24 Stockholm
Year: 2024
Authors: Sagoo, Pervinder